{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-038510","form_type":"8-K","ticker":"IDXG","cik":"0001054102","company_name":"INTERPACE BIOSCIENCES, INC.","filed_at":"2023-10-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.054979+00:00","generated_at":"2026-06-09T06:39:26.367283+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Interpace Biosciences amends BroadOak loan: $2.5M lump sum to satisfy $3M terminal payment, rate cut to 8%","bullets":["Lump sum payment of $2.5M due by Oct 31, 2023 in full satisfaction of $3M terminal payment under the Loan and Security Agreement.","Interest rate reduced from 9% to 8% per annum from Nov 1, 2023 through Oct 31, 2024.","Company may request extension of maturity date (Oct 31, 2024) with lender's sole discretion; 60-day notice required."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-038510","json":"https://secwatch.observer/filing/0001493152-23-038510.json","markdown":"https://secwatch.observer/filing/0001493152-23-038510.md","text":"https://secwatch.observer/filing/0001493152-23-038510.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1054102/000149315223038510/0001493152-23-038510-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1054102/000149315223038510/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T06:39:26.367283+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1175b701a5137899ea21f00126e59447a04ecbe8","claim":"INTERPACE BIOSCIENCES, INC. incurred credit facility of $2,500,000 with BroadOak Fund V, L.P. at 8.00% per annum.","evidence_excerpt":"Second Amendment ”) with BroadOak Fund V, L.P. (“ BroadOak ”), pursuant to which, among other things, the Company and BroadOak agreed to: (i) a payment of a lump sum payment of $2,500,000 on or prior to October 31, 2023 in full satisfaction of the $3,000,0000 terminal payment under the Loan and Security Agreement, dated October 29, 2021, as amended by the First","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1054102/000149315223038510/0001493152-23-038510-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"credit facility"},{"label":"Principal","value":"$2,500,000"},{"label":"Counterparty","value":"BroadOak Fund V, L.P."},{"label":"Rate","value":"8.00% per annum"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"},{"claim_id":"36abf68f8284ec8f5389bf07667568cb43e45119","claim":"INTERPACE BIOSCIENCES, INC. amended Second Amendment to Loan Security Agreement with BroadOak Fund V, L.P. valued at $2,500,000 (effective 2023-10-24).","evidence_excerpt":"On October 24, 2023, Interpace Biosciences, Inc. (the “ Company ”) and its subsidiaries entered into the Second Amendment to Loan Security Agreement (the “ Second Amendment ”) with BroadOak Fund V, L.P. (“ BroadOak ”), pursuant to which, among other things, the Company and BroadOak agreed to: (i) a payment of a lump sum payment of $2,500,000 on or prior to October 31, 2023 in full satisfaction of the $3,000,0000 terminal payment under the Loan and Security Agreement, dated October 29, 2021, as amended by the First Amendment to Loan and Security Agreement and Consent, dated May 5, 2022 (the “ Loan and Security Agreement ”); (ii) a reduction of the interest rate under the Loan and Security Agreement from nine percent (9.00%) per annum to eight percent (8.00%) per annum commencing on November 1, 2023 through October 31, 2024, or earlier, upon the occurrence of a change in control (the “ Maturity Date ”); and (iii) the Company’s right to extend the Maturity Date upon sixty (60) days’ writt","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1054102/000149315223038510/0001493152-23-038510-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"credit facility"},{"label":"Counterparty","value":"BroadOak Fund V, L.P."},{"label":"Value","value":"$2,500,000"},{"label":"Effective","value":"2023-10-24"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}